Cargando…
Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients
Generation of functional β cells from pluripotent sources would accelerate diagnostic and therapeutic applications for diabetes research and therapy. However, it has been challenging to generate competent β cells with dynamic insulin-secretory capacity to glucose and incretin stimulations. We introd...
Autores principales: | Zhu, Yaxi, Tonne, Jason M., Liu, Qian, Schreiber, Claire A., Zhou, Zhiguang, Rakshit, Kuntol, Matveyenko, Aleksey V., Terzic, Andre, Wigle, Dennis, Kudva, Yogish C., Ikeda, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700523/ https://www.ncbi.nlm.nih.gov/pubmed/31378674 http://dx.doi.org/10.1016/j.stemcr.2019.07.006 |
Ejemplares similares
-
Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetes
por: Lu, Brian, et al.
Publicado: (2018) -
Indolactam V/GLP-1-mediated Differentiation of Human iPS Cells into Glucose-Responsive Insulin-Secreting Progeny
por: Thatava, Tayaramma, et al.
Publicado: (2010) -
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy
por: Tonne, Jason M., et al.
Publicado: (2013) -
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration
por: El Khatib, Moustafa M., et al.
Publicado: (2016) -
The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients
por: Kukla, Aleksandra, et al.
Publicado: (2020)